The unsupervised analysis revealed that NPM1-mutated patients cluster together with MLL-translocated and NUP98-rearranged AML, but separately from the risk-matched CBF-rearranged AML (Figure 2A). This evidence concerns the gene CEBPZ and acute myeloid leukemia.